Burning Mouth Syndrome - New Diagnostic Criteria and Treatment

NCT05059418 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Burning Mouth Syndrome

Interventions

DRUG: Clonazepam 0.5 MG
DRUG: Capsaicin Topical
OTHER: Placebo

Sponsor

Malmö University

Collaborators

[object Object]